Francesc Almirall Alzamora

Francesc Almirall Alzamora currently serves as the Director of Commercial Operations & Launch Excellence at Blueprint Medicines since August 2022. Prior experience includes roles as the Director of Commercial Excellence & Planning at Nektar Therapeutics and Director of Patient Services & Device Strategy at Apellis Pharmaceuticals, where responsibilities encompassed EU commercial operations, patient support strategy, and device launch strategies. Francesc also held the position of Director of Global Brand Planning, Patient Value & Product Strategy at Takeda, and Director of Portfolio Management and Brand Planning at Shire, overseeing brand planning frameworks and global portfolio prioritization. Francesc enhanced digital marketing expertise through education at London Business School and IESE Business School.